Tag: IIb

KEYTRUDA Is the First Anti-PD-1/L1 Therapy to Show Recurrence-Free Survival Benefit in the Adjuvant Setting for Stage IIB and IIC Melanoma KEYTRUDA Is Now Approved as Adjuvant Treatment for Patients ...

Millions of medical students aspire to pass the NEET exam. However, not all of these candidates can clear it on the first try. NEET is a complex medical entrance exam ...

In the Phase IIb NATIVE, lanifibranor met both the primary and key secondary endpoints, including NASH resolution with no worsening of fibrosis and improvement of liver fibrosis with no worsening ...